Metsera Inc
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s $8.5 billion bid for the U.S. obesity drug developer to be a superior offer. Pfizer asked the Delaware court where it filed the lawsuit to issue a temporary restraining order to […]
Read More
Stocks making the biggest moves midday: Cigna, FormFactor, Meta Platforms, Microsoft, Carvana & more
Check out the companies making the biggest moves midday: Cigna — Shares of the health insurance company after management said during an earnings call that it expects its pharmacy benefit services division to face margin pressure in the next few years. Cardinal Health — The drug and medical equipment distributor surged more than 12% on […]
Read More
Novo Nordisk enters bidding war with Pfizer over U.S. biotech Metsera
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Denmark’s Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as drugmakers jostle for advantage in the fast-growing and competitive weight-loss drug market. Novo Nordisk, the company behind blockbuster weight loss drug Wegovy and diabetes […]
Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise. The company last week said it would buy […]
Read More
Stocks making the biggest moves midday: Oracle, Apple, Metsera, Compass, Kenvue and more
Check out the companies making headlines in midday trading : Better Home & Finance Holding — The mortgage lender briefly soared as much as 176% Monday after hedge fund manager Eric Jackson in a social media post on X called Better Home “the Shopify of mortgages” and said the company is rebuilding a $15 trillion […]
Read More
Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer on Monday said it would buy weight loss drugmaker Metsera in an up to $7.3 billion deal, including future payments, as it scrambles to win a slice in the booming obesity drug market. Pfizer said it will pay an initial $47.50 a share in […]
Read More
Stocks making the biggest premarket moves: Metsera, Compass, Kenvue, Fox & more
Check out the companies making headlines before the opening bell : Metsera , Pfizer — The weight-loss drugmaker soared 60% after an announcement it would be bought by Pfizer for $4.9 billion in cash. The deal is expected to close in the fourth quarter. Pfizer shares ticked nearly 3% higher. Anywhere , Compass — Brokerage […]
Read More